The risk of developing a mismatch repair deficient colorectal cancer after undergoing cholecystectomy

Scandinavian Journal of Gastroenterology
Matthias Orn HalldorssonSigurdis Haraldsdottir

Abstract

Mismatch repair deficient (dMMR) colorectal cancer (CRC) is caused by inactivation of the MMR DNA repair system, most commonly via epigenetic inactivation of the MLH1 gene, and these tumors occur most frequently in the right colon. The objective was to determine whether cholecystectomy (CCY) increases the risk of a dMMR CRC by comparing CCY incidence in patients with dMMR CRC and proficient MMR (pMMR) CRC to unaffected controls. All patients diagnosed with CRC in Iceland from 2000 to 2009 (n = 1171) were included. They had previously been screened for dMMR by immunohistochemistry (n = 129 were dMMR). Unaffected age- and sex-matched controls (n = 17,460) were obtained from large Icelandic cohort studies. Subjects were cross-referenced with all pathology databases in Iceland to establish who had undergone CCY. Odds ratios were calculated using unconditional logistic regression. Eighteen (13.7%) dMMR CRC cases and 90 (8.7%) pMMR CRC cases had undergone CCY compared to 1532 (8.8%) controls. CCY-related odds ratios (OR) were 1.06 (95% CI 0.90-1.26, p = .577) for all CRC, 1.16 (95% CI 0.66-2.05 p = .602) for dMMR CRCand 1.04 (95% CI 0.83-1.29, p = .744) for pMMR CRC. Furthermore, OR for dMMR CRC was 0.51 (95% CI 0.16-1.67, p = .266),...Continue Reading

References

Nov 1, 1995·Gastroenterology·D C Chung, A K Rustgi
Jun 30, 1995·Science·N PapadopoulosK W Kinzler
Mar 18, 1994·Science·N PapadopoulosM D Adams
May 7, 1993·Science·S N ThibodeauD Schaid
Jul 1, 1993·Gastroenterology·E GiovannucciM J Stampfer
Feb 1, 1996·Scandinavian Journal of Gastroenterology·F D ReidT Bates
Feb 6, 1999·The American Journal of Gastroenterology·I TodorokiW Samowitz
May 6, 2005·The New England Journal of Medicine·Heather HampelAlbert de la Chapelle
Mar 14, 2007·American Journal of Epidemiology·Tamara B HarrisVilmundur Gudnason
Aug 25, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Akke BotmaEllen Kampman
Nov 16, 2010·Gastroenterology·Constance E Ruhl, James E Everhart
Mar 3, 2012·European Journal of Preventive Cardiology·Erla SvansdottirHrobjartur D Karlsson
Jul 20, 2012·Nature·UNKNOWN Cancer Genome Atlas Network
Sep 19, 2012·Familial Cancer·Isabelle SourrouilleFlorent Soubrier
Jan 8, 2013·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Xiaonan XueMarc J Gunter
Jun 19, 2013·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Stefan StenderAnne Tybjaerg-Hansen
Mar 3, 2015·Genetics and Molecular Research : GMR·H YangW F Li
Apr 4, 2015·World Journal of Gastroenterology : WJG·Maria Coats, Sami M Shimi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.